Physician profile
William Thom
NPI 1225015456
$12,592.61
in general payments reported to CMS, 2019-2025
29 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,730 · 2020: $476 · 2021: $1,947 · 2022: $854 · 2023: $2,976 · 2024: $1,951 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,302 · Travel and Lodging: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,302.45 |
| Travel and Lodging | $1,283.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,436.75 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Synchromedii |
| Medtronic USA, INC. | $3,433.93 | 2019-2020 | |
| Relievant Medsystems, INC. | $984.62 | 2021-2023 | Intracept |
| Spr Therapeutics, INC | $813.55 | 2023-2025 | Sprint Pns System |
| Vertos Medical, INC. | $507.18 | 2021-2024 | Mild Device Kit |
| Nevro Corp. | $437.44 | 2024 | Senza, Vyrsa V1 |
| Tersera Therapeutics LLC | $325.63 | 2019 | |
| Stimwave Technologies Incorporated | $302.38 | 2019-2021 | |
| Boston Scientific Corporation | $250.70 | 2025 | Intracept |
| Trevena, INC. | $195.87 | 2021-2022 | |
| Globus Medical, INC. | $182.70 | 2025 | Vyrsa V1 |
| Zimvie INC. | $138.55 | 2023 | |
| Nalu Medical, INC. | $107.84 | 2023 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $99.00 | 2023 | Evoke Scs |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $55.91 | 2019-2021 | |
| Biogen, INC. | $45.86 | 2021 | |
| Allergan, INC. | $26.81 | 2019-2020 | |
| Abbott Laboratories | $24.91 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.94 | 2019 | |
| Uswm, LLC | $21.76 | 2021 | |
| Avanos Medical | $19.22 | 2023 | Coolief* Cooled Radiofrequency |
| Virtus Pharmaceuticals LLC | $18.91 | 2021 | |
| Pfizer INC. | $15.22 | 2020 | |
| Biodelivery Sciences International, INC. | $13.89 | 2021 | |
| Sentynl Therapeutics, INC. | $13.44 | 2019 | |
| Assertio Therapeutics, INC. | $13.41 | 2019 | |
| Shionogi INC | $12.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.